NCT01099436View on ClinicalTrials.gov

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

September 30, 2013

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

doxorubicin hydrochloride

DRUG

zoledronic acid

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

2300 RC

Leiden University Medical Center, Leiden

Sponsors

Collaborators (3)

Amgen
Sanofi
Novartis
All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

collaborator

Amgen

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

Novartis

INDUSTRY

lead

Borstkanker Onderzoek Groep

NETWORK